Internal Medicine, Endocrinology, Diabetes, & Metabolism · Springfield, MO
NPI
1225054109
Since 2006
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
3
Medicare group memberships
Hospitals
4
Hospital affiliations
960 E Walnut Lawn, Suite 201
Springfield, MO, 65807
Phone (417) 269-4450
Groups this clinician bills Medicare through
Medicare paid, 2024
$120K
3,800 services
Medicare patients, 2024
585
Average age 72
Drug cost, 2024
$1.6M
6,378 prescriptions
Company payments, 2025
$16K
From 23 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by James T Bonucchi was code J0897 (injection, denosumab, 1 mg), 1,020 times for 16 patients. In total James T Bonucchi billed 3,800 services in 66 codes, and Medicare paid $120K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2019-06-04.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0897 Injection, denosumab, 1 mg | Office | 1,020 | 16 | $20.80 | $21K |
| 36415 Venipuncture Blood Collection | Office | 414 | 326 | $8.65 | $3,581 |
| 99214 Office E&M - Established | Office | 360 | 342 | $81.81 | $29K |
| 84443 Clinical Chemistry | Office | 291 | 247 | $16.46 | $4,790 |
| 76536 Ultrasound - Nonspecific | Office | 203 | 194 | $71.27 | $14K |
| 84439 Clinical Chemistry | Office | 165 | 149 | $8.84 | $1,459 |
| 80048 Clinical Chemistry | Office | 157 | 145 | $8.29 | $1,302 |
| 99204 Office E&M - New | Office | 97 | 97 | $102.28 | $9,921 |
| 83036 Blood Count | Office | 75 | 67 | $9.52 | $714 |
| 10005 Other Organ Systems | Office | 66 | 61 | $89.95 | $5,937 |
| 99215 Office E&M - Established | Office | 52 | 52 | $122.87 | $6,389 |
| 84460 Clinical Chemistry | Office | 35 | 35 | $5.19 | $182 |
| 80061 Clinical Chemistry | Office | 30 | 30 | $13.12 | $394 |
| 99213 Office E&M - Established | Office | 30 | 30 | $46.64 | $1,399 |
| 82533 Clinical Chemistry | Office | 28 | 25 | $15.97 | $447 |
By year: 2022 $118K for 3,318 services; 2023 $111K for 2,912 services; 2024 $120K for 3,800 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 414 | 326 | $8.65 | $3,581 |
| 84443 Clinical Chemistry | 291 | 247 | $16.46 | $4,790 |
| 84439 Clinical Chemistry | 165 | 149 | $8.84 | $1,459 |
| 80048 Clinical Chemistry | 157 | 145 | $8.29 | $1,302 |
| 83036 Blood Count | 75 | 67 | $9.52 | $714 |
| 84460 Clinical Chemistry | 35 | 35 | $5.19 | $182 |
| 80061 Clinical Chemistry | 30 | 30 | $13.12 | $394 |
| 82533 Clinical Chemistry | 28 | 25 | $15.97 | $447 |
| 84481 Clinical Chemistry | 26 | 24 | $16.60 | $432 |
| 82570 Clinical Chemistry | 24 | 24 | $5.08 | $122 |
Medicare prescription drug claims, 2024
In 2024, the drug James T Bonucchi prescribed most often to Medicare patients was Levothyroxine Sodium, with 1,008 prescriptions and refills. In total James T Bonucchi wrote 6,378 Medicare prescriptions that cost $1.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 1,008 | 2,712 | 293 | $8,437 |
| Atorvastatin Calcium Generic | 409 | 1,068 | 122 | $2,804 |
| Metformin Hcl Generic | 310 | 688 | 81 | $1,565 |
| Rosuvastatin Calcium Generic | 219 | 562 | 65 | $1,863 |
| Lisinopril Generic | 209 | 482 | 56 | $920 |
| Jardiance Empagliflozin | 208 | 372 | 51 | $216K |
| Farxiga Dapagliflozin Propanediol | 207 | 321 | 41 | $177K |
| Nano 2nd Gen Pen Needle Pen Needle, Diabetic | 181 | 367 | 60 | $14K |
| Synthroid Levothyroxine Sodium | 164 | 401 | 45 | $14K |
| Losartan Potassium Generic | 162 | 452 | 58 | $1,353 |
| Methimazole Generic | 157 | 381 | 52 | $1,436 |
| Metformin Hcl Er Metformin Hcl | 145 | 397 | 47 | $1,317 |
| Toujeo Max Solostar Insulin Glargine,hum.Rec.Anlog | 131 | 208 | 36 | $108K |
| Ozempic Semaglutide | 129 | 180 | 38 | $167K |
| Amlodipine Besylate Generic | 114 | 295 | 41 | $562 |
Brand drugs: 2,591 claims; generic drugs: 3,492 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid James T Bonucchi $16K ($16K in general payments such as food, travel and fees) from 23 companies. The largest payer was Abbott Laboratories with $11K.
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories ABT | 38 | $11K |
| Lilly USA, LLC LLY | 9 | $2,867 |
| Dexcom, Inc. DXCM | 19 | $209 |
| Globus Medical, Inc. GMED | 6 | $197 |
| Amgen Inc. AMGN | 17 | $187 |
| Novo Nordisk Inc NVO | 10 | $180 |
| Insulet Corporation PODD | 5 | $122 |
| Neurocrine BioSciences, Inc. NBIX | 3 | $89.81 |
| Recordati_rare_diseases_inc. | 3 | $78.19 |
| Radius Health, Inc. | 3 | $74.54 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.